Last updated: June 19, 2020
Sponsor: Zagazig University
Overall Status: Active - Recruiting
Phase
2/3
Condition
Coronavirus
Covid-19
Corona Virus
Treatment
N/AClinical Study ID
NCT04445311
ZU-IRB#6151/31-5-2020
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: COVID-19 patients during period of the study more than 18 years old
Exclusion
Exclusion Criteria: refuse to participate pregnancy or lactation hypersensitivity to ivermectin receive anydrug with interaction with ivermectin
Study Design
Total Participants: 100
Study Start date:
May 31, 2020
Estimated Completion Date:
August 15, 2020
Connect with a study center
Waheed Shouman
Zagazig, Sharkia 44519
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.